France Biopsy Devices Market Forecast 2024-2032

The France biopsy devices market is projected to grow at a CAGR of 8.01% over the forecast years 2024-2032. The market growth is driven by several factors, comprising the rising prevalence of cancer, increasing demand for minimally invasive surgeries, and a surge in the number of hospitals and diagnostic centers.

MARKET INSIGHTS

The biopsy devices market in France is shaped by the high demand for biopsy devices due to the prevalence of cancer, including breast, prostate, and lung cancers. The market benefits from ongoing technological advancements, including minimally invasive techniques and the integration of artificial intelligence in pathology, enhancing the precision and efficiency of biopsy procedures. France's healthcare sphere emphasizes early detection and personalized medicine, aligning with the capabilities of biopsy devices to provide timely and accurate diagnostic information. The aging population contributes to increased demand for these devices, considering the elevated risk of diseases such as cancer with age.

Collaborations between medical device companies, research institutions, and healthcare providers promote innovation and the development of advanced biopsy technologies. Regulatory standards and compliance are integral considerations for companies operating in the biopsy devices market. Patient awareness and education initiatives further contribute to market growth, as informed patients play a key role in healthcare decision-making. As a result, these factors are set to stimulate the market's growth in France during the forecast period.

COMPETITIVE INSIGHTS

Some of the major companies in the France biopsy devices market include: Cardinal Health, Boston Scientific, Hologic Inc, etc.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation caters to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 78662

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. COUNTRY SNAPSHOT
2.3. COUNTRY ANALYSIS
2.4. SCOPE OF STUDY
2.5. CRISIS SCENARIO ANALYSIS
- 2.5.1. IMPACT OF COVID-19 ON BIOPSY DEVICES MARKET
2.6. MAJOR MARKET FINDINGS
- 2.6.1. GROWING EMPHASIS ON PERSONALIZED MEDICINE
- 2.6.2. EXPANDING APPLICATIONS ACROSS MEDICAL SPECIALITIES
- 2.6.3. DEVELOPMENT OF COST-EFFECTIVE BIOPSY SOLUTIONS

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. RISING PREVALENCE OF CANCER
- 3.1.2. INCREASING DEMAND FOR MINIMALLY INVASIVE SURGERIES
- 3.1.3. SURGE IN THE NUMBER OF HOSPITALS AND DIAGNOSTIC CENTERS
3.2. KEY RESTRAINTS
- 3.2.1. HIGH RISK OF INFECTION FOR PATIENTS
- 3.2.2. HIGH COST OF BIOPSY PROCEDURES
- 3.2.3. LACK OF SKILLED PROFESSIONALS

4. KEY ANALYTICS

4.1. KEY MARKET TRENDS
- 4.1.1. SURGE IN THE HEALTHCARE EXPENDITURE
- 4.1.2. SHIFT TOWARDS PREVENTIVE HEALTHCARE
- 4.1.3. ADVANCEMENTS IN BIOPSY TECHNOLOGY
4.2. PORTER'S FIVE FORCES ANALYSIS
- 4.2.1. BUYERS POWER
- 4.2.2. SUPPLIERS POWER
- 4.2.3. SUBSTITUTIONS
- 4.2.4. NEW ENTRANTS
- 4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
- 4.3.1. GROWTH PROSPECT MAPPING FOR FRANCE
4.4. VALUE CHAIN ANALYSIS
- 4.4.1. RAW MATERIALS
- 4.4.2. MANUFACTURERS
- 4.4.3. DISTRIBUTION
- 4.4.4. END-USERS

5. MARKET BY PRODUCT

5.1. NEEDLE- BASED BIOPSY GUNS
- 5.1.1. VACUUM-ASSISTED BIOPSY (VAB) DEVICES
- 5.1.2. FINE NEEDLE ASPIRATION BIOPSY (FNAB) DEVICES
- 5.1.3. CORE NEEDLE BIOPSY (CNB) DEVICES
5.2. BIOPSY GUIDANCE SYSTEMS
5.3. BIOPSY NEEDLES
5.4. BIOPSY FORCEPS
5.5. OTHER PRODUCTS

6. MARKET BY APPLICATION

6.1. ONCOLOGY
6.2. GASTROENTEROLOGY
6.3. PULMONOLOGY
6.4. DERMATOLOGY
6.5. OTHER APPLICATIONS

7. MARKET BY END USE

7.1. HOSPITALS
7.2. AMBULATORY SURGICAL CENTERS
7.3. DIAGNOSTIC CENTERS

8. COMPETITIVE LANDSCAPE

8.1. KEY STRATEGIC DEVELOPMENTS
- 8.1.1. MERGERS & ACQUISITIONS
- 8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 8.1.3. PARTNERSHIPS & AGREEMENTS
- 8.1.4. BUSINESS EXPANSIONS & DIVESTITURES
8.2. COMPANY PROFILES
- 8.2.1. CARDINAL HEALTH
- 8.2.2. HOLOGIC INC
- 8.2.3. DANAHER CORPORATION
- 8.2.4. CONMED CORPORATION
- 8.2.5. BOSTON SCIENTIFIC
- 8.2.6. BECTON DICKINSON AND COMPANY

Product Code: 78662

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - BIOPSY DEVICES
TABLE 2: FRANCE BIOPSY DEVICES MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: FRANCE BIOPSY DEVICES MARKET, BY PRODUCT, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 4: FRANCE BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY GUNS, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: FRANCE BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY GUNS, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 6: FRANCE BIOPSY DEVICES MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: FRANCE BIOPSY DEVICES MARKET, BY APPLICATION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 8: FRANCE BIOPSY DEVICES MARKET, BY END USE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: FRANCE BIOPSY DEVICES MARKET, BY END USE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 10: KEY PLAYERS OPERATING IN FRANCE BIOPSY DEVICES MARKET
TABLE 11: LIST OF MERGERS & ACQUISITIONS
TABLE 12: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 13: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 14: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING FOR FRANCE
FIGURE 4: VALUE CHAIN ANALYSIS
FIGURE 5: FRANCE BIOPSY DEVICES MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2023
FIGURE 6: FRANCE BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY GUNS, 2024-2032 (IN $ MILLION)
FIGURE 7: FRANCE BIOPSY DEVICES MARKET, GROWTH POTENTIAL, BY NEEDLE-BASED BIOPSY GUNS, IN 2023
FIGURE 8: FRANCE BIOPSY DEVICES MARKET, BY VACUUM-ASSISTED BIOPSY (VAB) DEVICES, 2024-2032 (IN $ MILLION)
FIGURE 9: FRANCE BIOPSY DEVICES MARKET, BY FINE NEEDLE ASPIRATION BIOPSY (FNAB) DEVICES, 2024-2032 (IN $ MILLION)
FIGURE 10: FRANCE BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY (CNB) DEVICES, 2024-2032 (IN $ MILLION)
FIGURE 11: FRANCE BIOPSY DEVICES MARKET, BY BIOPSY GUIDANCE SYSTEMS, 2024-2032 (IN $ MILLION)
FIGURE 12: FRANCE BIOPSY DEVICES MARKET, BY BIOPSY NEEDLES, 2024-2032 (IN $ MILLION)
FIGURE 13: FRANCE BIOPSY DEVICES MARKET, BY BIOPSY FORCEPS, 2024-2032 (IN $ MILLION)
FIGURE 14: FRANCE BIOPSY DEVICES MARKET, BY OTHER PRODUCTS, 2024-2032 (IN $ MILLION)
FIGURE 15: FRANCE BIOPSY DEVICES MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2023
FIGURE 16: FRANCE BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024-2032 (IN $ MILLION)
FIGURE 17: FRANCE BIOPSY DEVICES MARKET, BY GASTROENTEROLOGY, 2024-2032 (IN $ MILLION)
FIGURE 18: FRANCE BIOPSY DEVICES MARKET, BY PULMONOLOGY, 2024-2032 (IN $ MILLION)
FIGURE 19: FRANCE BIOPSY DEVICES MARKET, BY DERMATOLOGY, 2024-2032 (IN $ MILLION)
FIGURE 20: FRANCE BIOPSY DEVICES MARKET, BY OTHER APPLICATIONS, 2024-2032 (IN $ MILLION)
FIGURE 21: FRANCE BIOPSY DEVICES MARKET, GROWTH POTENTIAL, BY END USE, IN 2023
FIGURE 22: FRANCE BIOPSY DEVICES MARKET, BY HOSPITALS, 2024-2032 (IN $ MILLION)
FIGURE 23: FRANCE BIOPSY DEVICES MARKET, BY AMBULATORY SURGICAL CENTERS, 2024-2032 (IN $ MILLION)
FIGURE 24: FRANCE BIOPSY DEVICES MARKET, BY DIAGNOSTIC CENTERS, 2024-2032 (IN $ MILLION)